GTR Home > Tests > Focus::Oncomine™ NGS Panel

Overview

Test name

Help

Focus::Oncomine™ NGS Panel

Purpose of the test

Help

This is a clinical test intended for Help: Prognostic, Risk Assessment, Therapeutic management

Condition

Help

3 conditions tested. Click Indication tab for more information.

Methodology

Help
Molecular Genetics
XMutation scanning of select exons
Next-Generation (NGS)/Massively parallel sequencing (MPS)

Summary of what is tested

35 genes and variants. Click Methodology tab for more information.

Genes

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

How to order

Help

Not provided

Suggested reading

  • Pasche et al., 2014
    Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.

Practice guidelines

  • ASCO/CAP/IASLC/AMP, 2014
    Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.
  • KCPSG, 2014
    Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.
  • CAP/IASLC/AMP, 2013
    Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
  • KCPSG, 2013
    Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group.
  • AHRQ, 2013
    Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center